Atara Biotherapeutics, Inc. beat EPS estimates 0% of the time across 1 reported quarters (0 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | — | $-0.32 | — | Miss |
| Q12026 FY2026 | — | $-0.29 | — | Miss |
| Q42025 FY2025 | $-0.09 | $-0.25 | -177.8% | Miss |
Back to ATRA overview · ATRA holders · ATRA KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.